Tacrolimus Adverse Effects
Mostrando 1-5 de 5 artigos, teses e dissertações.
-
1. Evaluation of the use of tacrolimus ointment for the prevention of hypertrophic scars in experimental model
Abstract BACKGROUND: Tacrolimus, for its activity on modulation of collagen production and fibroblast activity, may have a role in the prevention of hypertrophic scars. OBJECTIVES: Evaluate macroscopic, microscopic, metabolic, laboratory effects and side effects of the use of topical tacrolimus ointment, in different concentrations, in the prevention of hy
An. Bras. Dermatol.. Publicado em: 09/05/2019
-
2. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review
Abstract Thus far, several small studies and case reports on the use of topical immunomodulators in vitiligo have been published. We undertook a comprehensive literature review, searching for studies evaluating clinical response to tacrolimus topical therapy for vitiligo. A search was performed on PubMed/Medline using the term “vitiligo”, combined with �
An. Bras. Dermatol.. Publicado em: 2016-04
-
3. Análise clínica evolutiva do uso do tacrolimus como droga imunossupressora em transplante cardíaco pediátrico / Clinical outcome of tacrolimus as maintenance immunosuppressive drug in pediatric heart transplantation
O Tacrolimus é uma potente droga imunossupressora introduzida no transplante cardíaco no início da década de 90. Pacientes com rejeição refratária ou intolerância à ciclosporina podem responder à terapia de resgate com o tacrolimus. Os objetivos deste estudo foram: avaliar a evolução clínica das crianças submetidas ao transplante cardíaco que
Publicado em: 2011
-
4. Eficácia, tolerabilidade e segurança do uso do sirolimo após o transplante renal / Efficacy, tolerability and safety of the use of sirolimus after kidney transplantation
Objectives: To evaluate the efficacy, safety and tolerability of the administration of sirolimus (SRL) and prednisone in combination with cyclosporine (CSA) or tacrolimus (TAC) after kidney transplantation. Methods: Retrospective study of 332 kidney transplants performed between 1999 and 2006. Primary efficacy endpoint included treatment failure, defined as
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 24/11/2010
-
5. Health-related quality of life outcomes after kidney transplantation
With the improvements in short and long term graft and patient survival after renal transplantation over the last two decades Health-Related Quality of Life (HRQL) is becoming an important additional outcome parameter. Global and disease specific instruments are available to evaluate objective and subjective QOL. Among the most popular global tools is the SF
BioMed Central.